Abstract
The development of activation/dissociation techniques such as ultraviolet photodissociation (UVPD), infrared multiphoton dissociation (IRMPD), and electron transfer dissociation (ETD) as alternatives to collision induced dissociation (CID) has extended the range of strategies for characterizing biologically relevant molecules. Here, we describe a comprehensive comparison of CID, IRMPD, UVPD, ETD, and hybrid processes termed ETcaD and ET-IRMPD (and analogous hybrid methods in the negative mode NETcaD and NET-IRMPD) for generating sequence-specific fragment ions and allowing adduction sites to be pinpointed for DNA/cisplatin adducts. Among the six MS/MS methods, the numerous products generated by the IRMPD and UVPD techniques resulted in the most specific and extensive backbone cleavages. We conclude that IRMPD and UVPD methods generally offer the best characteristics for pinpointing the cisplatin adduction sites in the fragment-rich spectra.
Similar content being viewed by others
References
Hurley, L.H.: DNA and its associated processes as targets for cancer therapy. Nat. Rev. Cancer 2(3), 188–200 (2002)
Ou, T.M., Lu, Y.J., Tan, J.H., Huang, Z.S., Wong, K.Y., Gu, L.Q.: G-quadruplexes: targets in anticancer drug design. Chem. Med. Chem. 3(5), 690–173 (2008)
Miller, K.M., Rodriguez, R.: G-quadruplexes: selective DNA targeting for cancer therapeutics? Expert. Rev. Clin. Pharmacol. 4(2), 139–142 (2011)
Rajski, S.R., Williams, R.M.: DNA cross-linking agents as antitumor drugs. Chem. Rev. 98(8), 2723–2795 (1998)
Brunton, L.L., Lazo, J.S., Parker, K.L.: Goodman and Gilman’s the pharmacological basis of therapeutics. McGraw-Hill, New York (2006)
Wheate, N.J., Brodie, C.R., Collins, J.G., Kemp, S., Aldrich-Wright, J.R.: DNA intercalators in cancer therapy: organic and inorganic drugs and their spectroscopic tools of analysis. Mini-Rev. Med. Chem. 7(6), 627–648 (2007)
Bischoff, G., Hoffmann, S.: DNA-binding of drugs used in medicinal therapies. Curr. Med. Chem. 9(3), 321–348 (2002)
Pommier, Y., Pourquier, P., Fan, Y., Strumberg, D.: Mechanism of action of eukaryotic DNA topoisomerase I and drugs targeted to the enzyme. Biochim. Biophys. Acta–Gene Struct. Expression 1400(1/3), 83–106 (1998)
Prestayko, A.W., Daoust, J.C., Issell, B.F., Crooke, S.T.: Cisplatin (cis-diamminedichloroplatinum-II). Cancer Treat. Rev. 6(1), 17–39 (1979)
Lippert, B.: Cisplatin: Chemistry and biochemistry of a leading anticancer drug. VHCA and Wiley-VCH: Zurich, Switzerland (1999)
Rosenberg, B., Van Camp, L., Krigas, T.: Inhibition of cell division in Escherichia coli by electrolysis products from a platinum electrode. Nature 205(4972), 698–699 (1965)
Boulikas, T., Vougiouka, M.: Recent clinical trials using cisplatin, carboplatin and their combination chemotherapy drugs (review). Oncol. Rep. 11(3), 559–595 (2004)
Loehrer, P.J., Einhorn, L.H.: Cisplatin. Ann. Intern. Med. 100(5), 704–713 (1984)
Muggia, F.: Platinum compounds 30 years after the introduction of cisplatin: implications for the treatment of ovarian cancer. Gynecol. Oncol. 112(1), 275–281 (2009)
Wong, E., Giandomenico, C.M.: Current status of platinum-based antitumor drugs. Chem. Rev. 99(9), 2451–2466 (1999)
Robins, A.B.: The reaction of 14C-labeled platinum ethylenediamine dichloride with adenine compounds and DNA. Chem.-Biol. Interact. 7(1), 11–16 (1973)
Robins, A.B.: The reaction of 14C-labeled platinum ethylenediamine dichloride with nucleic acid constituents. Chem.-Biol. Interact. 6(1), 35–45 (1973)
Mansy, S., Rosenberg, B., Thomson, A.J.: Binding of cis- and trans-dichlorodiammineplatinum(II) to nucleosides. I. Location of the binding sites. J. Am. Chem. Soc. 95(5), 1633–1640 (1973)
Fichtinger-Schepman, A.M.J., Van der Veer, J.L., Den Hartog, J.H.J., Lohman, P.H.M., Reedijk, J.: Adducts of the antitumor drug cis-diamminedichloroplatinum(II) with DNA: formation, identification, and quantitation. Biochemistry 24(3), 707–713 (1985)
Fichtinger-Schepman, A.M.J., van Oosterom, A.T., Lohman, P.H.M., Berends, F.: cis-Diamminedichloroplatinum(II)-induced DNA adducts in peripheral leukocytes from seven cancer patients: quantitative immunochemical detection of the adduct induction and removal after a single dose of cis-diamminedichloroplatinum(II). Cancer Res. 47(11), 3000–3004 (1987)
Mangrum, J.B., Farrell, N.P.: Excursions in polynuclear platinum DNA binding. Chem. Commun. 46(36), 6640–6650 (2010)
Jamieson, E.R., Lippard, S.J.: Structure, recognition, and processing of cisplatin-DNA adducts. Chem. Rev. 99(9), 2467–2498 (1999)
Poklar, N., Pilch, D.S., Lippard, S.J., Redding, E.A., Dunham, S.U., Breslauer, K.J.: Influence of cisplatin intrastrand crosslinking on the conformation, thermal stability, and energetics of a 20-mer DNA duplex. Proc. Natl. Acad. Sci. U. S. A. 93(15), 7606–7611 (1996)
Wu, J., McLuckey, S.A.: Gas-phase fragmentation of oligonucleotide ions. Int. J. Mass Spectrom. 237(2/3), 197–241 (2004)
Le Pla, R.C., Ritchie, K.J., Henderson, C.J., Wolf, C.R., Harrington, C.F., Farmer, P.B.: Development of a liquid chromatography-electrospray ionization tandem mass spectrometry method for detecting oxaliplatin-DNA intrastrand cross-links in biological samples. Chem. Res. Toxicol. 20(8), 1177–1182 (2007)
Beck, J.L., Colgrave, M.L., Ralph, S.F., Sheil, M.M.: Electrospray ionization mass spectrometry of oligonucleotide complexes with drugs, metals, and proteins. Mass Spectrom. Rev. 20(2), 61–87 (2001)
Anichina, J., Zhao, Y., Hrudey, S.E., Schreiber, A., Li, X.-F.: Electrospray ionization tandem mass spectrometry analysis of the reactivity of structurally related bromo-methyl-benzoquinones toward oligonucleotides. Anal. Chem. 83(21), 8145–8151 (2011)
Barry, J.P., Vouros, P., Vanschepdael, A., Law, S.J.: Mass and sequence verification of modified oligonucleotides using electrospray tandem mass spectrometry. J. Mass Spectrom. 30(7), 993–1006 (1995)
Iannitti-Tito, P., Weimann, A., Wickham, G., Sheil, M.M.: Structural analysis of drug-DNA adducts by tandem mass spectrometry. Analyst 125(4), 627–633 (2000)
Zhang, Q.R., Yu, E.T., Kellersberger, K.A., Crosland, E., Fabris, D.: Toward building a database of bifunctional probes for the MS3D investigation of nucleic acids structures. J. Am. Soc. Mass Spectrom. 17(11), 1570–1581 (2006)
Martin, L.B., Schreiner, A.F., Vanbreemen, R.B.: Characterization of cisplatin adducts of oligonucleotides by fast-atom-bombardment mass-spectrometry. Anal. Biochem. 193(1), 6–15 (1991)
Costello, C.E., Comess, K.M., Plaziak, A.S., Bancroft, D.P., Lippard, S.J.: Fast-atom-bombardment and highperformance tandem mass-spectrometry of platinum(II) oligoribonucleotide fragments. Int. J. Mass Spectrom. Ion Processes 122, 255–279 (1992)
Egger, A.E., Hartinger, C.G., Ben Hamidane, H., Tsybin, Y.O., Keppler, B.K., Dyson, P.J.: High resolution mass spectrometry for studying the interactions of cisplatin with oligonucleotides. Inorg. Chem. 47(22), 10626–10633 (2008)
Nyakas, A., Eymann, M., Schuerch, S.: The Influence of cisplatin on the gas-phase dissociation of oligonucleotides studied by electrospray ionization tandem mass spectrometry. J. Am. Soc. Mass Spectrom. 20(5), 792–804 (2009)
Nyakas, A., Stucki, S.R., Schurch, S.: Tandem mass spectrometry of modified and platinated oligoribonucleotides. J. Am. Soc. Mass Spectrom. 22(5), 875–887 (2011)
McLuckey, S., Van Berkel, G., Glish, G.: Tandem mass spectrometry of small, multiply charged oligonucleotides. J. Am. Soc. Mass Spectrom. 3(1), 60–70 (1992)
McLuckey, S.A., Habibi-Goudarzi, S.: Decompositions of multiply charged oligonucleotide anions. J. Am. Chem. Soc. 115(25), 12085–12095 (1993)
Wan, K.X., Gross, M.L., Shibue, T.: Gas-phase stability of double-stranded oligodeoxynucleotides and their noncovalent complexes with DNA-binding drugs as revealed by collisional activation in an ion trap. J. Am. Soc. Mass Spectrom. 11(5), 450–457 (2000)
Rosu, F., Pirotte, S., Pauw, E.D., Gabelica, V.: Positive and negative ion mode ESI-MS and MS/MS for studying drug–DNA complexes. Int. J. Mass Spectrom. 253(3), 156–171 (2006)
Smith, S.I., Brodbelt, J.S.: Rapid characterization of cross-links, mono-adducts, and noncovalent binding of psoralens to deoxyoligonucleotides by LC-UV/ESI-MS and IRMPD mass spectrometry. Analyst 135(5), 943–952 (2010)
Pierce, S.E., Guziec, L.J., Guziec, F.S., Brodbelt, J.S.: Characterization of aziridinylbenzoquinone dna cross-links by liquid chromatography-infrared multiphoton dissociation-mass spectrometry. Chem. Res. Toxicol. 23(6), 1097–1104 (2010)
Mazzitelli, C.L., Brodbelt, J.S.: Probing ligand binding to duplex dna using kmno4 reactions and electrospray ionization tandem mass spectrometry. Anal. Chem. 79(12), 4636–4647 (2007)
Groessl, M., Tsybin, Y.O., Hartinger, C.G., Keppler, B.K., Dyson, P.J.: Ruthenium versus platinum: interactions of anticancer metallodrugs with duplex oligonucleotides characterised by electrospray ionisation mass spectrometry. J. Biol. Inorg. Chem. 15(5), 677–688 (2010)
Reyzer, M.L., Brodbelt, J.S., Kerwin, S.M., Kumar, D.: Evaluation of complexation of metal-mediated DNA-binding drugs to oligonucleotides via electrospray ionization mass spectrometry. Nucleic Acids Res. 29(21), e103 (2001)
Smith, S.I., Guziec, L.J., Guziec, F.S., Hasinoff, B.B., Brodbelt, J.S.: Evaluation of relative DNA binding affinities of anthrapyrazoles by electrospray ionization mass spectrometry. J. Mass Spectrom. 42(5), 681–688 (2007)
Guan, Z.Q., Kelleher, N.L., Oconnor, P.B., Aaserud, D.J., Little, D.P., McLafferty, F.W.: 193 nm photodissociation of larger multiply-charged biomolecules. Int. J. Mass Spectrom. Ion Processes 157, 357–364 (1996)
Wilson, J.J., Brodbelt, J.S.: Infrared multiphoton dissociation of duplex dna/drug complexes in a quadrupole ion trap. Anal. Chem. 79(5), 2067–2077 (2007)
Smith, S.I., Brodbelt, J.S.: Characterization of oligodeoxynucleotides and modifications by 193 nm photodissociation and electron photodetachment dissociation. Anal. Chem. 82(17), 7218–7226 (2010)
Zubarev, R.A., Kelleher, N.L., McLafferty, F.W.: Electron Capture Dissociation of Multiply Charged Protein Cations. A Nonergodic Process. J. Am. Chem. Soc. 120(13), 3265–3266 (1998)
Budnik, B.A., Haselmann, K.F., Zubarev, R.A.: Electron detachment dissociation of peptide di-anions: an electron–hole recombination phenomenon. Chem. Phys. Lett. 342(3/4), 299–302 (2001)
Syka, J.E.P., Coon, J.J., Schroeder, M.J., Shabanowitz, J., Hunt, D.F.: Peptide and protein sequence analysis by electron transfer dissociation mass spectrometry. Proc. Natl. Acad. Sci. U. S. A. 101(26), 9528–9533 (2004)
Cooper, H.J., Hakansson, K., Marshall, A.G.: The role of electron capture dissociation in biomolecular analysis. Mass Spectrom. Rev. 24(2), 201–222 (2005)
Schultz, K.N., Hakansson, K.: Rapid electron canture dissociation of mass-selectively accumulated oligodeoxynucleotide dications. Int. J. Mass Spectrom. 234(1/3), 123–130 (2004)
Yang, J., Mo, J.J., Adamson, J.T., Hakansson, K.: Characterization of oligodeoxynucleotides by electron detachment dissociation Fourier transform ion cyclotron resonance mass spectrometry. Anal. Chem. 77(6), 1876–1882 (2005)
Smith, S.I., Brodbelt, J.S.: Electron transfer dissociation of oligonucleotide cations. Int. J. Mass Spectrom. 283, 85–93 (2009)
Smith, S.I., Brodbelt, J.S.: Hybrid activation methods for elucidating nucleic acid modifications. Anal. Chem. 83(1), 303–310 (2011)
Brodbelt, J.S., Wilson, J.J.: Infrared multiphoton dissociation in quadrupole ion traps. Mass Spectrom. Rev. 28(3), 390–424 (2009)
Little, D.P., Aaserud, D.J., Valaskovic, G.A., McLafferty, F.W.: Sequence information from 42-108-mer DNAs (complete for a 50-mer) by tandem mass spectrometry. J. Am. Chem. Soc. 118(39), 9352–9359 (1996)
Nyakas, A., Blum, L.C., Stucki, S.R., Reymond, J.-L., Schurch, S.: OMA and OPA software-supported mass spectra analysis of native and modified nucleic acids. J. Am. Soc. Mass Spectrom., in press (2012)
Acknowledgments
The authors gratefully acknowledge funding from NIH (RO1 GM65956) and the Welch Foundation (F1155).
Author information
Authors and Affiliations
Corresponding author
Electronic supplementary material
Below is the link to the electronic supplementary material.
ESM 1
(PPTX 1435 kb)
Rights and permissions
About this article
Cite this article
Xu, Z., Shaw, J.B. & Brodbelt, J.S. Comparison of MS/MS Methods for Characterization of DNA/Cisplatin Adducts. J. Am. Soc. Mass Spectrom. 24, 265–273 (2013). https://doi.org/10.1007/s13361-012-0532-6
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13361-012-0532-6